Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289416 · ClinicalTrials.gov registry record · Phase 4
Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis
A Phase 4 study of Knee Osteoarthritis, sponsored by Andrews Research & Education Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03289416: Completed Phase 4 study of Knee Osteoarthritis, sponsored by Andrews Research & Education Foundation.
NCT03289416 is a Phase 4 study of Knee Osteoarthritis that has completed, run by Andrews Research & Education Foundation. The registered enrollment target is 90 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03289416, a Phase 4 study of Knee Osteoarthritis, has completed, sponsored by Andrews Research & Education Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to compare whether bone marrow aspirate concentrate or platelet rich plasma injections is more effective in treating knee osteoarthritis.
Primary Outcome
Pain score measurements utilizing patient surveys; scale 0-20 with 20 being most pain and 0 being least pain
Conditions Studied
Interventions
- COMBINATION_PRODUCT Pure PRP II
- COMBINATION_PRODUCT PureBMC
Study Locations (1)
Florida
- Andrews Research & Education Foundation - Gulf Breeze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-12-05 |
| Est. Completion | 2020-02 |
| Phase | Phase 4 |
What the finished NCT03289416 record still lists
NCT03289416 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Pure PRP II is the first listed.
NCT03289416 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03289416 about?
NCT03289416 is a clinical study titled "Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis". This study is intended to compare whether bone marrow aspirate concentrate or platelet rich plasma injections is more effective in treating knee osteoarthritis.
What is the current status of trial NCT03289416?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2013-12-05. Estimated completion is 2020-02.
What conditions does trial NCT03289416 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT03289416?
The interventions under investigation include: Pure PRP II (COMBINATION_PRODUCT), PureBMC (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03289416?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03289416 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03289416's enrollment target sits among peer trials
90 49th of 101 higher than 52 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
RECRUITING · Phase 4
-
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
ACTIVE NOT RECRUITING · Phase 4
-
The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis
COMPLETED · Phase 4
-
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
COMPLETED · Phase 4
-
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI